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ABSTRACT
Introduction Integrating early detection and 
management of non- communicable diseases in primary 
healthcare has an unprecedented role in making 
healthcare more accessible particularly in low- and 
middle- income countries such as Ethiopia. This study 
aims to design, implement and evaluate an evidence- 
based intervention guided by the HEARTS technical 
package and implementation guide to address barriers 
and facilitators of integrating early detection and 
management of hypertension, diabetes mellitus and 
cardiovascular diseases in primary healthcare settings of 
Addis Ababa.
Methodology We will employ a type-3 hybrid 
implementation- effectiveness study from November 
2020 to May 2022. This study will target patients 
≥40 years of age. Ten health centres will be randomly 
selected from each subcity of Addis Ababa. The study 
will have four phases: (1) Baseline situational analysis 
(PEN facility- capacity assessment, 150 observations 
of patient healthcare provider interactions and 697 
patient medical record reviews), (2) Consolidated 
Framework for Implementation Research (CFIR) inspired 
qualitative assessment of barriers and facilitators (20 
in- depth interviews of key stakeholders), (3) Design of 
intervention protocol. The intervention will have capacity 
enhancement components including training of non- 
communicabledisease (NCDservice providers, provision 
of essential equipment/supporting materials and monthly 
monitoring and feedback and (4) Implementation 
monitoring and evaluation phase using the RE- AIM (reach, 
efficacy, adoption, implementation and maintenance) 
framework. Outcomes on early detection and management 
of NCDs will be assessed to examine the effectiveness of 
the study.
Ethics and dissemination plan Ethical clearance was 
obtained from the Addis Ababa University, College of 
Health Sciences Institutional Review Board and Addis 
Ababa Health Bureau. We plan to present the findings from 
this research in conferences and publish them in peer- 
reviewed journals.
INTRODUCTION
Non- communicable diseases (NCDs) are 
the leading causes of death worldwide. Inte-
grating cost- effective NCD interventions in 
primary healthcare, as the first point of care, 
has a great potential to reverse progression 
of disease, prevent complications, reduce 
hospitalisations, healthcare costs and out- of- 
pocket expenditures1 and make healthcare 
accessible.2 However, many African coun-
tries have health systems that do not meet 
the requirements for chronic disease care 
and are historically shaped around acute 
care.3 Management of NCDs is challenging 
especially in low- and middle- income coun-
tries due to the double burden of communi-
cable and non- communicable diseases, lack 
of human and material resources and other 
competing economic priorities in the coun-
tries.4 5 The long- term nature of many NCDs 
demand an integrated and comprehensive 
Strengths and limitations of this study
 ► The study uses an implementation research frame-
work to design interventions, analyse and report the 
findings of the study.
 ► The study uses a comprehensive baseline assess-
ment of health facilities to inform the design of the 
intervention.
 ► The study will adapt the WHO HEARTS technical 
package and implementation guide to the local con-
text to implement the intervention.
 ► The uncontrolled nature of the design might reduce 
the rigorousness of the study.
 ► As the outcome indicators for this study relies on 
routine medical records and observations, missing 
and observation bias might arise.
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health system response6 and need to be sustained for a 
significant period of time.7
A total of 57 million deaths occurred globally in 2016; 
of which, 41 million (71%) were due to NCDs, princi-
pally cardiovascular diseases (CVD), diabetes, cancer and 
chronic respiratory diseases.8 9 NCDs are responsible for 
15 million premature adult deaths (occurring in those 
aged 30 to 69 years). Nearly 80% of these premature deaths 
caused by NCDs occurred in low- and middle- income 
countries.10 Though communicable diseases are still the 
leading cause of mortality in Africa, the burden of NCDs 
is rising rapidly and is projected to cause almost three- 
quarters as many deaths as communicable, maternal, 
perinatal and nutritional diseases by 2020 and to exceed 
them as the most common causes of death by 2030.11 
Similarly, in Ethiopia, the burden of NCDs is increasing 
at an alarming rate. According to WHO country profiles, 
currently, NCDs are responsible for almost 39% of all 
deaths in Ethiopia.9
Strengthening the national capacity to integrate and 
scale- up care for major NCDs such as diabetes, CVD and 
respiratory disease in primary healthcare in low- resource 
settings were among the top recommendations.4 5 Over 
the years, the WHO has developed evidence informed 
guidelines to enhance the prevention, diagnosis and 
management of NCDs such as diabetes, CVD and respi-
ratory disease at primary healthcare settings. Among 
these guidelines are the package of essential non- 
communicable disease (PEN) and the total risk approach 
where cost- effective interventions for early detection 
of NCDs, non- pharmacological and pharmacological 
approaches for modification of risk factors and afford-
able medications for treatment of NCDs.4 In addition, in 
2016, the HEARTS technical package was developed as 
a measure to avert CVD by addressing major modifiable 
risk factors including tobacco use, hypertension, high 
blood cholesterol and diabetes.5 The package includes 
simple and affordable tools (eg, clinical measurements, 
simple laboratory testing, CVD risk assessment charts and 
blood pressure measurement devices) for early detection 
and treatment of CVDs. Moreover, these two guidelines 
are aligned and complementary to each other.5
Studies in sub- Saharan Africa indicated the impor-
tance of NCD integration models12 and effectiveness 
of advice on diet and lifestyle modification to facilitate 
management of NCDs in resource poor settings.13 The 
government of Ethiopia also produced a national guide-
line, championing integration of early detection and 
management of NCDs in primary healthcare to address 
the national burden of NCDs.14
Despite these initiatives, there is lack of evidence on 
practical implementation of guidelines, as well as little 
research on barriers and facilitators of early detection 
and management of NCDs in Ethiopia.
This study aims to design, implement and evaluate 
an evidence- based intervention guided by the HEARTS 
technical package and implementation guide to address 
barriers and facilitators of integrating early detection 
and management of hypertension, diabetes mellitus and 
CVDs in primary healthcare settings of Addis Ababa. The 
intervention will comprise capacity enhancement compo-
nents including development of training module and job- 
aids, training of NCD service providers, provision and/
or maintenance of essential equipment, guidelines and 
supporting materials and regular monitoring and feed-
back. With this study protocol, we will present how we will 
inform the design of the intervention and how we plan to 
implement and evaluate the intervention.
METHODS AND MATERIALS
Study settings
The study will be conducted in Addis Ababa, Ethiopia. 
Addis Ababa city administration is the capital city of the 
country. It is organised in 10 subcities, which are the 
second upper administration units next to the city admin-
istration. Addis Ababa has an estimated total population 
of 5.65 million, with an average density of 5645.61 people 
per square km. According to the 2017/2018 Health and 
Health Related Indicators of Ethiopia, the city has 25 
hospitals and 97 health centres.15 A health centre is the 
health service nearest to the public, where people receive 
direct and primary healthcare services. In Addis Ababa, a 
health centre serves approximately 25 000 people under 
its catchment area. It provides both preventive and cura-
tive services and serves as a referral centre.16 Health 
centres are also the first contact points for NCD screening, 
detection and management. On average, health centres 
are staffed with 20 healthcare providers, of whom 5 
healthcare providers work in adult outpatient depart-
ments (OPDs).16 Health centres report to subcity health 
bureaus, while the subcity health bureau is in charge of 
implementing a monthly mentorship programme as a 
standard procedure for each health centre providing 
NCD services in Addis Ababa. Mentors from subcities visit 
their respective health centres to supervise the quality 
of NCD services and provide written feedback to service 
providers and health centres.
Health centres in Addis Ababa are stratified in to 10 
subcities. We excluded 27 health centres with an ongoing 
intervention on NCDs. From the remaining pool of 70 
health centres, we randomly selected 1 health centre 
from each subcity to obtain a total of 10 health centres. 
Thus, the study will be conducted in 10 health centres 
(figure 1).
Study design and period
This study will employ a type-3 hybrid implementation- 
effectiveness design17 and will be conducted from 
November 2020 to May 2022. The study will be conducted 
in four phases, each described in detail below (figure 2):
Phase one: baseline situational analysis
This first phase will form the baseline assessment stage of 
the project and employ the following approaches.
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1. Caseload of major NCDs including hypertension and 
diabetes in the selected 10 health centres during 
the previous 3 months before the baseline data 
collection will be summarised by reviewing the Health 
Management Information System (HMIS) reports of 
health centres.
Figure 1 Sampling procedure and allocation of health centres, healthcare providers and patient medical records. NCDs, non- 
communicable diseases; OPD, outpatient department.
Figure 2 Schematic representation of the overall study design and timeline. CFIR, Consolidated Framework for 
Implementation Research; NCDs, non- communicable diseases; RE- AIM, reach, efficacy, adoption, implementation and 
maintenance; SARA, Service Availability and Readiness Assessment.
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2. Capacity of the selected 10 health centres to diagnose and 
manage NCDs will be conducted using the PEN facil-
ity capacity assessment4 and Service Availability and 
Readiness Assessment (SARA)18 tools. The tools in-
clude assessment of availability and functionality of 
essential diagnostic tools, medications, laboratory fa-
cilities and tests and human resources to provide NCD 
services.
3. Early detection and management of NCDs will be assessed 
using the following approaches by adapting the as-
sessment tools from WHO PEN and the clinical and 
programmatic management of major NCDs, Ethiopia 
guideline.14 19
1. Onsite observation of patient healthcare provider interac-
tions of patients ≥40 years of age attending the OPD 
in the selected health centres will be conducted. 
The observation will be guided by an observation 
checklist. The checklist will include information 
about risk assessment, diagnosis and counselling 
on adherence to medication and dietary and life-
style modifications. We will conduct three consec-
utive observations of patient healthcare provider 
interactions from each provider working in OPDs 
for patients ≥40 years of age in the selected health 
centres resulting in a total of 15 observations from 
each health centre (n=150) (figure 1). Data col-
lection will be conducted on all days of the week 
until the desired sample size is achieved. Data will 
be collected at each health centre at the same time. 
Background information of healthcare providers 
including age, educational status, years of work ex-
perience and previous training on NCDs will be col-
lected using a self- administered questionnaire after 
the observation.
2. Medical records of patients ≥40 years of age during the 
baseline data collection will be reviewed to assess 
opportunistic screening, risk assessment, manage-
ment of patients and extent of recording/documen-
tation of information on assessments, medications, 
laboratory analysis and dietary and lifestyle charac-
teristics of patients in the selected health centres. 
Patient medical records are paper based and stored 
in health centres. We estimated the number of pa-
tient’s medical records to be reviewed using a single 
population proportion. The following assumption 
was considered to obtain the minimum sample size: 
the prevalence of hypertension among outpatient 
clients in Addis Ababa 34.7%,20 95% precision and 
adjusting for design effect of 2, the calculation re-
sulted in a minimum of 697 patient medical records 
to be reviewed. This sample will be proportionally 
allocated to the selected 10 health centres based 
on their monthly average caseload. Sampling frame 
will be obtained from each health centre triage and 
simple random sampling will be used to select pa-
tient medical records (figure 1).
Data collection procedure of phase one
The first phase of the study will be conducted from 
November 2020 to January 2021. Data on baseline situa-
tional analysis will be collected by 10 health professionals. 
The data collection process will be overseen by five 
research assistants who are also health professionals. Data 
collectors and research assistants will be trained on the 
data collection process and tools by the research team.
Analysis of phase one
Data from situational analysis, PEN facility capacity assess-
ment, SARA, observation and review of medical records 
will be analysed using descriptive analysis techniques and 
will be presented using frequency tables, percentages, 
mean and median.
Phase two: assessment of barriers and facilitators
In this phase two, early detection and management of 
major NCDs will employ a qualitative study design. The 
research team will develop an in- depth qualitative inter-
view guide using a consolidated framework for imple-
mentation research, which is compatible to analyse both 
patient- level and system- level determinants. The frame-
work also accounts environmental thinking by providing 
theory- based constructs for developing context- specific 
models.21 22 The interview guide will be prepared in 
English, which will then be translated to the local 
language Amharic by a language expert and translated 
back to English to verify its consistency. The in- depth 
interview will target key stakeholders including health-
care providers working in OPD, pharmacy, laboratory, 
patients ≥40 years of age (both patients with NCD and 
other conditions), health centre administrative, represen-
tatives of subcity, Addis Ababa Health Bureau, Ministry of 
Health, health centre HMIS and Pharmaceuticals Fund 
and Supply Agency (PFSA). PFSA is a sole government led 
supplier of medication, laboratory reagents and essential 
medical equipment in Ethiopia.
Data collection procedure of phase two
This phase of the study will be conducted from February 
2021 to April 2021. We plan to conduct 20 in- depth inter-
views of key stakeholders. However, based on the satu-
ration of the data, further theoretical sampling will be 
considered. Four experienced qualitative interviewers 
who are health professionals will conduct the in- depth 
interviews after receiving a training about the purpose 
of the study and components of the interview guide. All 
in- depth interviews will be audiotaped.
Consolidated Framework for Implementation Research
The aim of this study is to improve early detection and 
management of NCDs in primary healthcare services of 
Addis Ababa. It is important to understand the context of 
primary care facilities in order to document the nuances 
of the current scenario. Using theory- derived frameworks 
to improve the early detection and management of NCDs 
in low- income countries like Ethiopia will help to generate 
robust evidence to back up policies. Thus, we will use the 
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Consolidated Framework for Implementation Research 
(CFIR) framework to understand the contextual barriers 
and facilitators related to early detection and manage-
ment of NCDs particularly hypertension and diabetes at 
primary healthcare level in Addis Ababa.21 Over the past 
years, the use of this framework is increasing, especially 
in helping healthcare systems identify why health inter-
ventions are not working and on identifying hurdles to 
and acceptability of new interventions. The framework is 
a synthesis of different implementation frameworks into 
one consolidated framework with 39 constructs organ-
ised under five domains (intervention characteristics, 
outer setting, inner setting, characteristics of individ-
uals and process) (box 1). Our data collection tool will 
be designed to include all the five domains of the CFIR 
framework and we will try to cover as much constructs as 
possible depending on the saturation of the interviews.
Data analysis of phase two
Qualitative interviewers will transcribe the audiotaped 
in- depth interviews into Amharic and then translate it 
to English language. The authors of the study will verify 
the translated interviews against the audiotapes for accu-
racy. English version of the transcript will be prepared 
in text files and entered into Open Code software for 
processing and analysis. Two individuals with experience 
in qualitative analysis will make the coding line by line. 
We will follow thematic analysis based on the domains 
and constructs of CFIR framework. Codes, categories, 
patterns and quotations will be analysed into the precon-
ceived codebook from the CFIR domains and constructs 
as they emerge in the interview transcripts. Accordingly, 
the barriers and the facilitators will be identified. Along 
with the finding from the quantitative study, the research 
team will triangulate the evidence to assist further plan-
ning and development of intervention protocol.
Phase three: design of intervention protocol
During this phase, we will design an intervention protocol 
tailored to address barriers and adaptation of the imple-
mentation on the existing systems to improve early detec-
tion and management of patients ≥40 years of age. This 
design phase will be informed by the findings of the 
earlier phases and the HEARTS technical package and 
implementation guide.5 23 The intervention protocol will 
include the following capacity enhancement and moni-
toring components and will be developed from May 2021 
to June 2021. The outlined intervention will be further 
strengthened based on the results of our baseline assess-
ment and the identification of the barriers and facilitators.
1. Development of training materials including training 
module and job- aids guided by the findings of earlier 
phases and the WHO PEN and HEARTS packages. The 
training module will consist of information regarding 
early detection and management of NCDs, counselling 
skills, recording and reporting.
2. Training of healthcare providers working in OPD, lab-
oratory pharmacy and triage, subcity mentors/super-
visors, representatives from health centre administra-
tion, health centre HMIS representative, PFSA. The 
training will be provided by internists, endocrinologists 
and public health nutrition professionals from Addis 
Ababa University. A 3- day training will be provided 
once at the beginning of the implementation phase. 
It will include PowerPoint presentations, question and 
answer sessions and role- plays.
3. Provision of guidelines and supporting materials such as 
HEARTS technical package, job- aids and posters to be 
placed/posted inside the OPD, recording and report-
ing charts, copies of the national standard recording 
and reporting templates. Guidelines and supporting 
materials will be provided based on the gaps in the 
monthly monitoring reports throughout the imple-
mentation phase.
4. Provision and/or maintenance of essential equipment such as 
blood pressure and glucose measuring devices, weight 
scale, height measuring device/stadiometer and waist 
circumference measuring tape. Essential equipment 
will be provided and/or maintained based on the gaps 
in the monthly monitoring reports throughout the im-
plementation phase. The study team will liaise with the 
Ministry of Health, Addis Ababa Health Bureau and 
non- governmental organisations to provide/maintain 
Box 1 CFIR (Consolidated Framework for Implementation 
Research) domains and associated constructs
1. Intervention characteristics
 ► Intervention source
 ► Evidence strength and quality




 ► Design quality
 ► Cost
2. Outer setting
 ► Patient needs and resources
 ► Cosmopolitanism
 ► Peer pressure
 ► External policy and incentives
3. Inner setting
 ► Structural characteristics
 ► Networks and communication
 ► Culture implementation climate
 ► Readiness for implementation
4. Characteristics of individuals
 ► Knowledge and beliefs about the intervention
 ► Self- efficacy
 ► Individual stage of change





 ► Reflecting and evaluation
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essential equipment, guidelines and supporting mate-
rials to deliver NCD services.
5. Facilitation of medication and laboratory reagent procurement 
from the national PFSA in case of stock out through-
out the implementation phase. The study team will fa-
cilitate procurement by assisting the health centres in 
writing procurement request before a complete stock 
out to allow time for the procurement process. We will 
also assist health centres to have regular monitoring of 
the availability and functionality of essential medica-
tions, reagents and equipment.
6. Maintaining clean and comfortable environment in NCD 
service rooms for patient healthcare provider consulta-
tions. The study team will make sure that NCD service 
rooms are clean and comfortable during the monthly 
monitoring.
7. Monthly monitoring and feedback of the NCD services will 
be conducted for 5 months.
Phase four: implementation, monitoring and evaluation phase
In this phase, we will implement the intervention protocol 
in the selected 10 health centres. After the training 
and provision of essential equipment, we will conduct 
monthly monitoring of the health centres with feedback 
for 5 months in addition to the regular monthly mento-
ring/supervision visits conducted by subcity mentors. We 
will adapt a checklist from WHO PEN package to guide 
the monitoring visits. The checklist will include avail-
ability and functionality of essential tools, medications, 
equipment and trained staff and regularity/functionality 
of the subcity mentorship and feedback programme. 
After each monitoring visit, a performance report will be 
prepared, and best practices/lessons learnt will be docu-
mented to capitalise the experience for the rest of the 
health centres. Appropriate written feedback will then 
be provided to respective health centres, NCD service 
providers and subcity mentors at each monitoring visit. 
The feedback will be provided by trained health profes-
sionals who are involved in the data collection process. 
We will also provide and/or maintain essential tools and 
equipment for health centres based on the gaps in the 
monitoring reports.
As part of continuous monitoring, we will assess early 
detection and management of NCDs every month for 5 
months using the same observation checklist and patient 
medical records reviewing tool used during the baseline 
assessment. The variables in the observation checklist and 
patient medical record reviews will be organised using the 
RE- AIM framework by Glasgow et al (1999)24 to evaluate 
certain dimensions of the intervention and implementa-
tion process (online supplemental table 1). The frame-
work will assess five dimensions of the implementation at 
individual and organisation level; reach, efficacy, adop-
tion, implementation and maintenance.
Outcome measures
This study will measure outcomes related to NCD detec-
tion and management at primary healthcare level. 
Outcomes will be assessed through review of patient 
medical records, onsite observation of patient health-
care provider interactions, review of HMIS reports and 
monthly monitoring reports.
The outcomes to be measured in this study are as 
follows: Further, key outcome measures of the study under 
each dimensions of the RE- AIM framework are presented 
as a supplement along this paper (online supplemental 
table 1). We will display outcome measures for each data 
collection month from baseline to end line.
1. Assessment and counselling: % of individuals ≥40 
years of age for whom blood pressure, blood glucose 
and waist circumference measured, % of individuals 
≥40 years of age for whom cardiovascular risk estimat-
ed and % of individuals ≥40 years of age who received 
dietary and lifestyle counselling in each month of data 
collection.
2. Treatment and control of NCDs: effectiveness of 
NCD management and control programme will be 
evaluated using indicators such as % of individu-
al who received antihypertensive and antidiabetic 
medications, % of individuals with blood pressure 
>140/90 mm Hg, % individuals with random blood 
sugar >140 mg/dL or fasting blood sugar >110 mg/
dL, % individuals with cardiovascular risk >30%, % 
of individuals with high waist circumference (>80 cm 
in women and >90 cm in men), % individuals with 
hypertension and diabetes related complications 
and % individuals with lifestyle modifications in each 
month of data collection.
Data collection procedure of phase four
Phase four of the study will be conducted from July 2021 
to May 2022. Trained health professionals involved during 
the baseline data collection and monitoring will collect 
data for this phase.
Analysis of phase four
Monthly monitoring reports will be compiled to 
produce a summary of the reports including best prac-
tices/lessons learnt and feedbacks. Data from obser-
vation checklists and review of medical records will be 
analysed using descriptive analysis techniques such as 
frequencies, percentages, mean and median. Monthly 
data for all collected variables will be presented in a 
table to show the changes/progresses each month. 
Trend of monthly reports will be compared using Χ2 
for trend analysis.
DISCUSSION
A comprehensive understanding of the organisational 
situations, readiness, service availability and barriers and 
facilitators to early detection and management of NCDs 
are important to implement an innovative approach to 
integrate the service at the primary healthcare level. In 
addition, locally customised intervention towards NCDs 
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will enhance the overall healthcare system and help 
policymakers to make evidence informed decisions.
In this study, a representative sample, one health 
centre from each subcity in Addis Ababa was selected. 
We excluded health centres with an ongoing interven-
tion. Furthermore, the study aims to derive learning from 
context and develop a set of working interventions and 
best practices, which can be transferred to other settings. 
Thus, the findings from this study can be generalised to 
urban settings of Ethiopia and could serve as a lesson for 
other places with similar setting.
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